CD36 and metabolic dysfunction-associated steatotic liver disease: Furthermore, Zeng et al. [63] reported that palmitoylation of CD36 is significantly upregulated in NAFLD and that inhibition of this palmitoylation alleviates NAFLD by promoting CD36 localization to the mitochondria of hepatocytes.